Department of Biochemistry, D.Y. Patil Medical college and Hospital Kolhapur, Maharashtra, 416005, India , dipalimangave1878@gmail.com
Abstract: (252 Views)
Background: Diabetes mellitus is an endocrine disorder. It is one of the leading causes of morbidity and mortality due to its role in the development of microvascular and macrovascular complications. The main pathophysiological features of type 2 diabetes mellitus are impaired insulin secretion and increased insulin resistance (IR). There is a relationship between fasting serum insulin, IR, and beta-cell dysfunction. Familial aggregation is a significant risk factor for early-onset type 2 diabetes mellitus. First-degree relatives not only share genetic predispositions but also socio-environmental risk factors like obesity and hyperglycemia, forming a high-risk group.
Methods: The study population consists of 60 people, including healthy controls (n = 20), first-degree relatives (n = 20), and diabetes patients (n = 20). The level of serum fasting insulin was measured by the chemiluminescence immunoassay method. IR was calculated using mathematical formulas such as HOMA-IR and HOMA-B.
Results: The results showed that the level of serum insulin increased in the FDR group (8.5 ± 5.6) compared to the diabetic and control groups (p < 0.001). HOMA-IR was significantly increased in individuals with diabetes (2.10 ± 1.10) and the FDR group (1.81 ± 1.25) compared to controls (p < 0.0001). We also noted a strong positive correlation between fasting serum insulin and HOMA-IR in the FDR group (r = +0.98) and in diabetic patients (r = +0.79).
Conclusion: Serum fasting insulin is an excellent and dependable marker for diagnosing IR in individuals at risk of developing diabetes, including FDR.
Methods: The study population consists of 60 people, including healthy controls (n = 20), first-degree relatives (n = 20), and diabetes patients (n = 20). The level of serum fasting insulin was measured by the chemiluminescence immunoassay method. IR was calculated using mathematical formulas such as HOMA-IR and HOMA-B.
Results: The results showed that the level of serum insulin increased in the FDR group (8.5 ± 5.6) compared to the diabetic and control groups (p < 0.001). HOMA-IR was significantly increased in individuals with diabetes (2.10 ± 1.10) and the FDR group (1.81 ± 1.25) compared to controls (p < 0.0001). We also noted a strong positive correlation between fasting serum insulin and HOMA-IR in the FDR group (r = +0.98) and in diabetic patients (r = +0.79).
Conclusion: Serum fasting insulin is an excellent and dependable marker for diagnosing IR in individuals at risk of developing diabetes, including FDR.
Keywords: Diabetes Mellitus, First degree relatives
Article Type: Research |
Subject:
Biochemistry
References
1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimation for the year 2000 and projection for 2030. Diabetes Care. 2004;27(5):1047-53. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Usgaonkar AP, Dhume CY, Amonkar SD. Comparative assessment of insulin sensitivity and pancreatic beta cell function in diabetic and non-diabetics. Int J Pharm Bio Sci. 2012;3(1):B-405-13. [View at Publisher] [Google Scholar]
3. Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance in Gan D, editor. Diabetes Atlas, International Diabetes Federation. 3rd ed. Belgium:International Diabetes Federation;2006. p.15-103 [View at Publisher] [Google Scholar]
4. Vishwanathan M, McCarthy MI, Snehalatha C, Hitman GA, Ramachandran A. Familial Aggregation of type 2 (non-insulin-dependent) diabetes mellitus in South India; Absence of excess maternal transmission. Diabet Med. 1996;13(3):232-7. [View at Publisher] [DOI] [PubMed] [Google Scholar]
5. Rana G, Khurshid R. Early metabolic defects, including oral glucose tolerance, serum insulin, and blood glycated hemoglobin, in different age groups of first-degree relatives have increased the risk for diabetes mellitus. IRJBCS. 2013;1(2):16-21. [View at Publisher]
6. Vishwanathan M, McCarthy MI, Snehalatha C, Hitman GA, Ramachandran A. Familial Aggregation of type 2 (non-insulin-dependent) diabetes mellitus in South India; Absence of excess maternal transmission. Diabet Med. 1996;13(3):232-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Kohei K. Pathophysiology of type 2 diabetes and its treatment policy. Journal of the Japan Medical Association. 2010;53(1):41-6. [View at Publisher] [Google Scholar]
8. Srihardyastutie A, Soeatmadji DW, Fatchiyah, Aulanni. The relationship between HbA1c, insulin resistance and changes of insulin secretion in Indonesian type 2 diabetic subject. Advances in Natural and Applied Sciences. 2014;8(8):25-30. [View at Publisher] [Google Scholar]
9. Verma M, Paneri S, badi P, Raman PG. Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity. Indian J Clin Biochem. 2006;21(1):142-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Sathiyapriya V, Bobby Z, Agrawal A, Selvaraj N. Protein glycation, insulin sensitivity and pancreatic beta cell dysfunction in higher risk for non-diabetic, first degree relatives of patients with type 2 diabetes. Indian J Physiol Pharmacol. 2009;53(2):163-8. [View at Publisher] [PMID] [Google Scholar]
11. Kumar A, Tiwari P, Sahoo S, Shrivastava AK. Prevalence of insulin resistance in first degree relatives of T2DM patients: a prospective study in north Indian population. Indian J Clin Biochem. 2005;20(2):10-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostatic model assessment: Insulin resistance and beta cell function from man's plasma glucose and insulin concentrations. Diabetologia. 1985;28:412-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Mastsude M, Defronzo RA. In vivo measurement of insulin sensitivity in humans. Clinical Research in Diabetes Obesity.1997;1:23-65. [View at Publisher] [Google Scholar]
14. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999;22(5):818-22. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Kawasaki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, et al. Homeostasis Model Assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24(2):362-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Tripathi P, Kadam N, Tiwari D, Vyawahare A, Sharma B, Kathrikolly T, et al. Oral glucose tolerance test clearance in type 2 diabetes patients who underwent remission following intense lifestyle modification: A quasi-experimental study. Plos One. 2024;19(5):e0302777. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Vaidya RA, Desai S, Moitra P, Salis S, Agashe S, Battalwar R, et al. Hyperinsulinemia: an early biomarker of metabolic dysfunction. Front Clin Diabetes Healthc. 2023 May 2:4:1159664. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Chow EY, Chan JC. Insulin resistance versus β-cell dysfunction in type 2 diabetes: where public and personalised health meet. Lancet Diabetes Endocrinol. 2020;8(2):92-3. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Saisho Y. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes. 2015;6(1):109-24. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).